Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook

Core Insights - Glucose Health, Inc. has appointed Mark Schaftlein as CEO and Marc Hatch as CFO and COO, effective October 20, 2025, indicating a strategic leadership transition [1][4] - Both executives bring significant experience and investment to the company, aligning their interests with those of shareholders [4] Management Appointments - Mark Schaftlein has over 25 years of leadership experience in U.S. public markets and has served as CEO for various emerging-growth companies, providing expertise in regulatory and operational complexities [2] - Marc Hatch has extensive experience in operations and marketing, focusing on optimizing sales performance and managing consumer-facing operations [3] Investment and Financial Support - A core group of investors has contributed nearly $2 million to Glucose Health, enabling the establishment of its brands, GlucoDown® and Fiber Up®, which have gained commercial traction [5] - The company has achieved revenues nearing $1.1 million in the recent fiscal year while maintaining gross margins above 40%, demonstrating operational efficiency [7] Product Development and Market Position - GlucoDown® and Fiber Up® are soluble fiber drink mixes formulated with resistant dextrin, recognized by the FDA for its benefits in lowering post-prandial blood sugar [6] - The company has successfully expanded its retail presence, doubling its pharmacy store count and competing with established brands like Boost®, Glucerna®, and Metamucil® [7] Future Focus - Under the new leadership, Glucose Health, Inc. aims to continue focusing on execution, product excellence, and long-term value creation for shareholders and consumers [8]